Staphyt and GenoScreen join forces to offer integrated solutions in genomics, regulatory studies and field trials
21/01/2026 — Staphyt, a leading contract research organization (CRO) and regulatory affairs consultant for agricultural experimentation and risk assessment, and GenoScreen, a pioneer and specialist in genomic and bioinformatics solutions, are pleased to announce the signing of a strategic collaboration agreement.
New EFSA Guidance for microorganisms (2025) : What changes and how GenoScreen help you stay fully compliant
Following its agenda to regulate the Food and Feed industry with up-to-date regulatory texts, the EFSA significantly raised the technical expectations for the characterisation and risk assessment of microorganisms used in food and feed. As of November 4th, 2025, dossiers that rely on outdated genomic analysis, incomplete resistance screening or legacy databases may no longer […]
How to scientifically and regulatory validate a probiotic or postbiotic Strain (EFSA, FDA)?
What are the requirements for marketing a probiotic or postbiotic strain? Developing supplements or functional foods containing a biotic strain involves much more than simply demonstrating their effectiveness. This process is essential for obtaining regulatory approvals from authorities such as the European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration (FDA) :
From prebiotic to LBP: Measuring functional effects in the gut microbiome
An imbalanced microbiome is not only characterized by a lack of diversity or abundance of species. What truly matters are the functions expressed:
How to prove the efficacy of a probiotic or postbiotic using genomics?
Biotics — whether prebiotics, probiotics, or postbiotics — are at the core of nutritional and therapeutic strategies aimed at preserving or restoring gut microbiota balance. However, with increasing regulatory requirements (EFSA, FDA) and growing market competition, it is crucial to demonstrate their efficacy through robust scientific evidence.
GenoScreen and Clear Labs Announce the Launch of Clear Dx™ Deeplex® Myc-TB, an Automated Genomic Solution for Mycobacterium Characterization and TB Drug Resistance Detection
GenoScreen announces the launch of Clear Dx™ Deeplex® Myc-TB, developed in collaboration with Clear Labs.
Updated guidelines for Novel Food submissions (EU) 2015/2283
The 1st of February 2025 entered into force the “Guidance on the scientific requirements for an application of a novel food in the context of Regulation (EU) 2015/2283”.
What is EFSA?
EFSA stands for the European Food Safety Authority. It is essentially the scientific supervisor of the European Union when it comes to food. EFSA’s purpose is to ensure that the food Europeans eat is safe and meets high quality standards. To do so, they provide objective and unbiased scientific assessment of food-related risks.
What is the QPS list?
The European Food Safety Authority (EFSA ) plays a crucial role in ensuring the safety of the food and feed supply chain. A key element in this process is the Qualified Presumption of Safety (QPS) list.
How to preserve the skin microbiota?
The skin microbiota plays a vital role in maintaining the skin’s integrity and functionality. It contributes to the proper regulation of organisms and organs, allowing the skin to perform its essential functions, including acting as a barrier. See our latest article “Why preservce the skin microbiota ?”